Key facts
- It has raised $16.4M; the latest was Later Stage VC in Dec 2024.
- Notable investors include Tech Incubator Program for Startup, Premier Partners, AFW Partners, ActnerLab, Allico Pharmaceutical — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for MEDITULIP
- ·The full record, as it builds
Funding rounds
No funding rounds for MEDITULIP are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MEDITULIP
Developer of medical devices designed for advanced minimally invasive surgery. The company develops a novel asymmetrical linear stapler that helps to take tissue samples for frozen section biopsy from the true resection margin and confirms the radicality of cancer surgery intraoperatively, enabling surgeons to conduct surgical procedures more efficiently.
- Sector
- Healthcare
- HQ
- Cheongju, South Korea
- Founded
- 2015
- Employees
- 28
- Website
- meditulip.co.kr/
- Ownership
- Privately Held (backing)
MEDITULIP doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MEDITULIP shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MEDITULIP in its N-PORT filings yet. We sweep new filings monthly.